MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robida, A. M.
Right arrow Articles by Murphy, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robida, A. M.
Right arrow Articles by Murphy, T. J.

Vol. 58, Issue 4, 701-708, October 2000

Cyclosporin A Selectively Inhibits Mitogen-Induced Cyclooxygenase-2 Gene Transcription in Vascular Smooth Muscle Cells

Aaron M. Robida, Kaiming Xu, Michelle L. Ellington, and T. J. Murphy

Department of Pharmacology, Emory University School of Medicine (A.M.R., K.X., M.L.E., T.J.M.), and the Program in Molecular and Systems Pharmacology, Graduate Division of Biological and Biomedical Sciences, Emory University (A.M.R., T.J.M.), Atlanta, Georgia

The prostaglandin synthase cyclooxygenase-2 (COX-2) is produced by an immediate early response gene induced in most cells by a variety of stimuli. Several studies have shown that the immunosuppressant cyclosporin (CsA) interferes with prostanoid metabolism, but the mechanisms are unclear. Here we examine the effect of CsA on COX-2 mRNA induction in cultured rat vascular smooth muscle cells (VSMC) that natively express the nuclear factor of activated T-cells, a known mediator of CsA-sensitive transcription. CsA significantly suppresses strong COX-2 mRNA induction caused by the Ca2+-mobilizing mitogens UTP, angiotensin II, and platelet-derived growth factor-BB, and the synergistic induction caused by costimulation with ionomycin and a phorbol ester. Forskolin and interleukin-1beta are substantially weaker COX-2 mRNA inducers, and CsA does not inhibit their effect. CsA strongly inhibits UTP-, angiotensin II-, and platelet-derived growth factor-BB-stimulated COX-2 gene transcription as measured by nuclear run-on or promoter-reporter studies, but has no effect on mRNA induction caused by post-transcriptional stabilization of a distal COX-2 mRNA 3'-untranslated region regulatory element. These data show that CsA selectively inhibits mitogen-induced COX-2 gene expression by a transcriptional mechanism that may involve the nuclear factor of activated T-cells.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Biol. Reprod.Home page
M.-R. Du, W.-H. Zhou, L. Dong, X.-Y. Zhu, Y.-Y. He, J.-Y. Yang, and D.-J. Li
Cyclosporin A Promotes Growth and Invasiveness In Vitro of Human First-Trimester Trophoblast Cells Via MAPK3/MAPK1-Mediated AP1 and Ca2+/Calcineurin/NFAT Signaling Pathways
Biol Reprod, June 1, 2008; 78(6): 1102 - 1110.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Xu, C. M. Kitchen, H.-K. G. Shu, and T. J. Murphy
Platelet-derived Growth Factor-induced Stabilization of Cyclooxygenase 2 mRNA in Rat Smooth Muscle Cells Requires the c-Src Family of Protein-tyrosine Kinases
J. Biol. Chem., November 9, 2007; 282(45): 32699 - 32709.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. G. Jackson, Y. M. Usachev, and S. A. Thayer
Bradykinin-Induced Nuclear Factor of Activated T-Cells-Dependent Transcription in Rat Dorsal Root Ganglion Neurons
Mol. Pharmacol., August 1, 2007; 72(2): 303 - 310.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Zhang, P. Hopwood, C. C. Abrams, A. Downing, F. Murray, R. Talbot, A. Archibald, S. Lowden, and L. K. Dixon
Macrophage Transcriptional Responses following In Vitro Infection with a Highly Virulent African Swine Fever Virus Isolate.
J. Virol., November 1, 2006; 80(21): 10514 - 10521.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. D. Peavy, K. B. Hubbard, A. Lau, R. B. Fields, K. Xu, C. J. Lee, T. T. Lee, K. Gernert, T. J. Murphy, and J. R. Hepler
Differential Effects of Gq{alpha}, G14{alpha}, and G15{alpha} on Vascular Smooth Muscle Cell Survival and Gene Expression Profiles
Mol. Pharmacol., June 1, 2005; 67(6): 2102 - 2114.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Damirin, H. Tomura, M. Komachi, M. Tobo, K. Sato, C. Mogi, H. Nochi, K. Tamoto, and F. Okajima
Sphingosine 1-Phosphate Receptors Mediate the Lipid-Induced cAMP Accumulation through Cyclooxygenase-2/Prostaglandin I2 Pathway in Human Coronary Artery Smooth Muscle Cells
Mol. Pharmacol., April 1, 2005; 67(4): 1177 - 1185.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Duque, M. Fresno, and M. A. Iniguez
Expression and Function of the Nuclear Factor of Activated T Cells in Colon Carcinoma Cells: INVOLVEMENT IN THE REGULATION OF CYCLOOXYGENASE-2
J. Biol. Chem., March 11, 2005; 280(10): 8686 - 8693.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Vila-del Sol and M. Fresno
Involvement of TNF and NF-{kappa}B in the Transcriptional Control of Cyclooxygenase-2 Expression by IFN-{gamma} in Macrophages
J. Immunol., March 1, 2005; 174(5): 2825 - 2833.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-E. Janelle, A. Gravel, J. Gosselin, M. J. Tremblay, and L. Flamand
Activation of Monocyte Cyclooxygenase-2 Gene Expression by Human Herpesvirus 6. ROLE FOR CYCLIC AMP-RESPONSIVE ELEMENT-BINDING PROTEIN AND ACTIVATOR PROTEIN-1
J. Biol. Chem., August 16, 2002; 277(34): 30665 - 30674.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. L. Abbott, J. R. Loss II, A. M. Robida, and T. J. Murphy
Evidence That Galpha q-Coupled Receptor-Induced Interleukin-6 mRNA in Vascular Smooth Muscle Cells Involves the Nuclear Factor of Activated T Cells
Mol. Pharmacol., November 1, 2000; 58(5): 946 - 953.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics